Stablepoint Partners LLC grew its position in MetLife, Inc. (NYSE:MET – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 57,317 shares of the financial services provider’s stock after purchasing an additional 247 shares during the period. Stablepoint Partners LLC’s holdings in MetLife were worth $4,693,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. MeadowBrook Investment Advisors LLC lifted its holdings in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 186 shares during the period. Wolff Wiese Magana LLC lifted its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new position in shares of MetLife in the 3rd quarter valued at approximately $30,000. Finally, Retirement Wealth Solutions LLC bought a new stake in shares of MetLife during the fourth quarter worth $32,000. 94.99% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have issued reports on MET. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. BMO Capital Markets initiated coverage on shares of MetLife in a report on Thursday. They issued a “market perform” rating and a $97.00 price objective on the stock. JPMorgan Chase & Co. increased their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Finally, Wells Fargo & Company lowered their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $90.46.
MetLife Stock Down 0.9 %
MET stock opened at $85.96 on Friday. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The business’s 50 day simple moving average is $83.81 and its 200 day simple moving average is $79.98. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $59.52 billion, a PE ratio of 17.33, a PEG ratio of 0.65 and a beta of 1.07.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.54%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s payout ratio is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Most Volatile Stocks, What Investors Need to Know
- MP Materials: Rare Earth Elements Powering the EV Boom
- Differences Between Momentum Investing and Long Term Investing
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- What is a support level?
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.